Skip to main content
Back to Top

 

Maria Katapodi, PhD, RN, FAAN

Credentials

Assistant Professor,
Robert Wood Johnson Foundation Nurse Faculty Scholar,
School of Nursing,
University of Michigan at Ann Arbor

Biography

Dr. Katapodi is an Assistant Professor in the Division of Acute, Critical and Long-Term Care at the University of Michigan School of Nursing and a Robert Wood Johnson Foundation Nurse Faculty Scholar. She is a member of the University of Michigan Comprehensive Cancer Center and the Indiana Behavioral Cooperative Oncology Group.  She received her PhD in nursing from the University of California at San Francisco.
Dr. Katapodi's area of research focuses on breast cancer prevention, decision-making around cancer screening, genetic testing for hereditary cancer, family communication around the genetics of cancer, and perceived risk.  Over the past 10 years she has examined cognitive and affective mechanisms that influence perceived risk, decision-making, and screening behaviors.  For the past 5 years her research is focused on women that carry deleterious mutations that predispose them to breast and ovarian cancer, i.e., perceived risk and family communication, decisional conflict related to use of genetic testing, and risk-reducing and cancer screening behaviors of high-risk women. Dr. Katapodi received a Robert Wood Johnson Foundation award to develop and test an intervention that enhances family communication and provides decision support to families that harbor a cancer-predisposing mutation.  Recently, she received an award from CDC for a dissemination study aiming to increase screening and risk-reduction behaviors among young breast cancer survivors (i.e., women whose age of diagnosis suggests hereditary/ familial breast cancer) and their high-risk female relatives.  Finally, she has expertise in meta-analysis methodology and has conducted and published two meta-analyses projects. The first meta-analysis examined the association between perceived breast cancer risk and screening behaviors. The second meta-analysis examined the effects of interventions targeting family members of cancer patients.